HIV drug swap proves safe in landmark trial

This study looked at whether people with HIV who have their virus under control can switch from the injectable drug enfuvirtide to the oral pill raltegravir. 170 participants were randomly assigned to either stay on their current treatment or switch to raltegravir. The goal was to see if the switch was just as good at keeping the virus suppressed. The study found that switching was safe and effective, offering a more convenient treatment option.